The global Intrathecal Pumps Market is estimated at around US$ 231.5 million in 2022. With a projected CAGR of 5.2% for the next ten years, the market is likely to reach a valuation of nearly US$ 383.5 million by the end of 2032. Intrathecal pumps require substantially less medication compared to oral drugs, owing to which its demand is on a constant rise.
| Report Attributes | Details |
|---|---|
| Intrathecal Pumps Market Size (2021A) | US$ 221.1 million |
| Estimated Market Value (2022E) | US$ 231.5 million |
| Forecasted Market Value (2032F) | US$ 383.5 million |
| Global Market Growth Rate (2022 to 2032) | 5.2% CAGR |
| United States Market (2022) | US$ 79.4 million |
| Key Companies Covered |
|
Future Market Insights’ analysis reveals that in 2022 revenue through the Intrathecal Pumps Market is estimated at US$ 231.5 million. Patients who have not seen relief from conservative pain management (CPT) treatments can benefit most from the adoption of intrathecal pumps. The intrathecal pumps market is one of the fastest-growing areas in pain management therapies around the globe.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for the Intrathecal Pumps Market expanded at a CAGR of 4.2% from 2017 to 2021. The National Cancer Institute estimates that 442.4 new instances of cancer are diagnosed annually for every 100 thousand men and women. Since intrathecal pumps work directly in the CSF and enable pharmaceuticals to be absorbed more quickly and directly than oral treatments, they are more advantageous than oral medications. This has accelerated the global market for intrathecal pumps.
The United States will continue to be the largest consumer of the Intrathecal Pumps, throughout the analysis period accounting for over US$ 51.7 million absolute dollar opportunity in the coming 10-year period.
Pain is a prevalent and clinically significant illness in the aging population. However, the use of intrathecal pumps has led to better results in the treatment of senior patients with pain. Unfortunately, evaluating pain in geriatric patients is problematic, mostly due to the complexity of multiple comorbidities. The demand for intrathecal pumps will continue to rise as the number of the elderly population grows. The WHO projects that by 2050, there will be 2 billion individuals worldwide who are 60 years of age or older.
The capacity of a pump to deliver medications where they are most frequently required, as well as their increased potency, reduced systemic exposure, and the amount necessary to have the desired pharmacologic effect, is anticipated to drive market expansion. For instance, Flowonix Medicals produced a 40 mL pump for injecting medications into the intrathecal region. The delivery device uses a pressure-driven, valve-gated delivery mechanism and has a battery life of more than 10 years, which can help prevent the need for future surgical procedures.
In comparison to the conservative pain management procedure for our initial implantation cycle, IDD therapy is less expensive. The following costs are cumulative US$ 17,317 greater than those for the conservative pain management procedure in the month of IDD implantation, although IDD breaks even financially shortly after the second year post-implant. According to the lifetime analysis, IDD saves US$ 3,111 per patient annually compared to conservative pain management.
The desire for affordable treatments like intrathecal pumps has increased in response to growing global concern over how to reduce rising healthcare costs. A patient satisfaction survey on intrathecal pumps conducted in 2020 found that 76.9% of respondents had avoided the hospital after receiving an intrathecal implant, which significantly reduced the expenditures associated with healthcare consumption.
Principal Consultant
The use of all intrathecal pumps has not yet been approved by the American Food and Drug Administration. The FDA has warned medical professionals and patients about the harmful repercussions of using medications that have not received FDA approval. Drugs that are approved for intrathecal use must also adhere to more stringent safety standards.
The market expansion could be hampered by hazards such as dosing errors, infections, pump failure, opioid withdrawal, and other conditions like muscular spasms, cognitive problems, discomfort, fever, vomiting, weakness, and heart or respiratory distress. CSF leak, surgical site infection, and catheter site irritation are examples of surgical complications. Between 0.5% and 2.0% of intrathecal implants result in surgical infections.
Additionally, it is projected that the global lack of anesthesiologists and neurosurgeons will have a negative effect on market growth. Intrathecal pumps are superior to conventional drug delivery methods in a number of ways, but their application is constrained by related technical and surgical issues. The technological issues include pump failure and catheter kinks, disconnections, and obstructions (battery depletion, pump inversion, & pump erosion). Although none of these mechanical faults provide a life-threatening risk, they all need specialized modification.
North America dominated the global intrathecal pumps market and accounted for a revenue share of over 40% in 2020. Growth in the market is anticipated to be fueled by the rising frequency of cancer and other related disorders, such as persistent back and neck pain. For instance, the Centers for Disease Control and Prevention (CDC) estimates that around 50 million Americans suffer from chronic pain. Additionally, improving patient outcomes and safety is of the utmost significance. Several programs have been formed to do this in the United States. Another element influencing its expansion is the fact that North America spends significantly more on healthcare than any other region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States will account for over 18.8 million of the global Intrathecal Pumps Market by the year 2032. The market growth from 2017 to 2021 was estimated at 3.5% CAGR. A malignant tumor of the brain or spinal cord affected over 24 thousand people in the United States in 2021, according to a report by the American Cancer Society.
The International Agency for Research on Cancer (IARC of WHO) recently released a report stating that there are now significantly more cancer patients. According to estimates, there are approximately 14.1 million cancer patients. Also, it was calculated that 8.2 million people will die from cancer each year. Future market growth is anticipated due to the rising incidence of cancer.
The market for intrathecal pumps in the United Kingdom. stood at US$ 10.7 million in 2021. By 2032, the market in the country is projected to reach a valuation of US$ 19.7 million, growing at a CAGR of 5.7% from 2022 to 2032. The market is expected to witness an absolute dollar opportunity of US$ 8.4 million during the forecast period.
In Japan, the market for intrathecal pumps accounted for US$ 9.4 million in 2021. From 2022 to 2032, the market accounted for an absolute dollar opportunity of US$ 9 million, growing at a CAGR of 6.8%. The market in the country is expected to reach a valuation of US$ 18.8 million by 2032.
The intrathecal pumps market in South Korea accounted for a valuation of US$ 4.8 million in 2021. By 2032, the market is expected to reach a valuation of US$ 8.3 million. Growing at a CAGR of 5.2%, the market is projected to garner an absolute dollar opportunity of US$ 3.3 million.
The market for morphine intrathecal pumps is projected to grow at a CAGR of 4.8% from 2021 to 2032. One of the most efficient treatments for severe chronic pain, intrathecal morphine injection is typically used as a part of a long-term therapy plan. Since morphine opioids are used 90% of the time in clinical settings, which is considered to be the gold standard for the management of postoperative pain, it is anticipated that this will drive segment growth.
The market through pain application held the largest revenue share of more than 70% in 2021. The segment is estimated to grow at a CAGR of 4.9% from 2021 to 2032. Many chronic diseases, including cancer, include pain as a component, and chronic pain is emerging as a distinct health issue with serious consequences for individuals. Around 1.5 billion people worldwide suffer from chronic pain, and its incidence rises with age, according to the School of Public Health at Boston University. About 50 million people in the United States suffer from chronic pain, with 20 million of those suffering from high-impact chronic pain, according to the Centers for Disease Control and Prevention (CDC).
Some of the key companies operating in the Intrathecal Pumps Market include Medtronic, Smiths Medical, Flowonix Medical Inc., triumphed Medizintechnik GmbH, Teleflex Incorporated, Johnson and Johnson Services, Inc., Durect Corporation, Medallion Therapeutics, Inc., Abbott, Baxter International Inc., Codman & Shurtleff, Inc., DePay Synthes, Summit Medical Group, B Braun Melsungen AG, Becton, Dickinson & Company and Fresenius Medical Care AG & Co. KGaA., and Zimmer Biomet.
Some of the recent developments by key providers of the Intrathecal Pumps Market are as follows:
Similarly, recent developments related to companies manufacturing Intrathecal Pumps have been tracked by the team at Future Market Insights, which is available in the full report.
The global market was valued at US$ 221.1 million in 2021.
The market is set to witness a growth rate of 5.2% over the forecast period and be valued at US$ 383.5 million by 2032.
The market expanded by 4.2% from 2017 through 2021.
The key players are Tricumed Medizintechnik GmbH, Arthrex Inc., Teleflex Incorporated, Flowonix Medical Inc, and Zimmer Biomet.
United States, United Kingdom, China, Japan, and South Korea are expected to drive the most sales growth in the Intrathecal Pumps Market.
The market in China accounts for US$ 43.6 million by 2032.
The United States holds the largest market share of the global market with US$ 51.7 million of absolute dollar opportunity.
1. Executive Summary | Intrathecal Pumps Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Baclofen 5.3.2. Bupivacaine 5.3.3. Clonidine 5.3.4. Morphine 5.3.5. Ziconotide 5.3.6. Other Types 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Application, 2017 to 2021 6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Application, 2022 to 2032 6.3.1. Spasticity 6.3.2. Pain 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa (MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. The United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Application 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Malaysia 11.2.1.5. Singapore 11.2.1.6. Australia 11.2.1.7. New Zealand 11.2.1.8. Rest of APAC 11.2.2. By Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Application 11.4. Key Takeaways 12. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Application 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. The USA 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Type 13.1.2.2. By Application 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Type 13.2.2.2. By Application 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Type 13.3.2.2. By Application 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Type 13.4.2.2. By Application 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Type 13.5.2.2. By Application 13.6. The United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Type 13.6.2.2. By Application 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Type 13.7.2.2. By Application 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Type 13.8.2.2. By Application 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Type 13.9.2.2. By Application 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Type 13.10.2.2. By Application 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Type 13.11.2.2. By Application 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Type 13.12.2.2. By Application 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Type 13.13.2.2. By Application 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Type 13.14.2.2. By Application 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Type 13.15.2.2. By Application 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Type 13.16.2.2. By Application 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Type 13.17.2.2. By Application 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Type 13.18.2.2. By Application 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Type 13.19.2.2. By Application 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Type 14.3.3. By Application 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Tricumed Medizintechnik GmbH 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.1.5.2. Product Strategy 15.1.1.5.3. Channel Strategy 15.1.2. Arthrex Inc. 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.2.5.2. Product Strategy 15.1.2.5.3. Channel Strategy 15.1.3. Teleflex Incorporated 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.3.5.2. Product Strategy 15.1.3.5.3. Channel Strategy 15.1.4. Flowonix Medical Inc. 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.4.5.2. Product Strategy 15.1.4.5.3. Channel Strategy 15.1.5. Zimmer Biomet 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.5.5.2. Product Strategy 15.1.5.5.3. Channel Strategy 15.1.6. Medtronic 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.6.5.2. Product Strategy 15.1.6.5.3. Channel Strategy 15.1.7. Smith’s Medical 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.7.5.2. Product Strategy 15.1.7.5.3. Channel Strategy 15.1.8. Durex Corporation 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.8.5.2. Product Strategy 15.1.8.5.3. Channel Strategy
Explore Healthcare Insights
View Reports
Intrathecal Pumps Market
